North America Intradermal Injections Market Forecast to 2028

Report Code : TIPRE00027994 | Region : North America | Industry : Pharmaceuticals | Published Date : 24/Nov/2022
North America Intradermal Injections Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Method (Normal Sized Needle, Short Needle, and Without Needle), Application (Tuberculin Skin Test, Allergy Test, Local Aesthetics, and Others), and End User (Hospitals, Diagnostic Laboratories, Academics and Research Institutes, and Others)

The intradermal injections market in North America is expected to grow from US$ 1,342.54 million in 2021 to US$ 2,859.32 million by 2028. It is estimated to grow at a CAGR of 11.4% from 2021 to 2028.

Strategic Developments by Manufacturers is Expected to Drive the Markets

Manufacturers in the North America intradermal injection market are adopting strategies such as partnerships, collaborations, product launches, approvals, and mergers and acquisitions to sustain the competition. They are also focused on partnerships to strengthen their presence in the market and to boost clinical research for accelerating the development of new drugs. For instance, in January 2021, Pharmajet partnered with the US Army Medical Research Institute of Infectious Diseases (USAMRIID) with an aim of utilizing the Pharmajet needle-free jet injector to deliver gene therapy developed by USAMRIID for treating small-pox; the therapy is commercially available under the name 4pox. Further, Inviragen and PharmaJet collaboration received an investment of US$ 15.5 million for an investigational dengue vaccine—DENVax—administered via Pharmajet’s needle-free injection device. Further, Crossject and Cenexi partnered in 2016 to develop a needle-free autoinjector named Zeneo. Thus, medical equipment manufacturers in North America are scaling up the production of their devices, along with introducing innovative products and ensuring the easy availability of their products. Moreover, regulatory agencies are providing the required support through timely product approvals and permissions. Such favorable conditions for manufacturers are bolstering the growth of the North America intradermal injection market.

Market Overview

The US, Canada, and Mexico are the key contributors to the intradermal injections market in the North America. The US is the largest contributor to the market in this region, and the market growth in the US is attributed to factors such as increase in incidences of tuberculosis, allergies, etc.; comprehensive clinical research and contract research ongoing in the country; and surging adoption of aesthetic cosmetic procedures. Moreover, the country is well ahead of other developed and emerging countries in terms of technology development and adoption, which has been favoring the development of various innovative intradermal injections and their applications in the healthcare sector. Tuberculosis (TB) is one of the leading bacterial infections in developed countries, including the US. According to the CDC, ~13 million people in the US are living with latent TB, while more than 7,000 cases of tuberculosis are diagnosed newly every year. As the tuberculin skin test is the primary test for the diagnosis of this disease, the demand for intradermal injections continues to grow with the rising cases of TB. The incidences of various allergic reactions are also increasing in the US; various allergies constitute the 6th leading reason for chronic illness in the country. According to the Asthma and Allergy Foundation of America, more than 50 million Americans experience allergic reactions. Moreover, ~30,000 people experienced anaphylaxis due to food every year, while ~7.7% of the adult population and 7.2% of children experience hay fever every year. The annual cost incurred by the healthcare sector due to allergies is also rising in the US. With a surge in the cases of skin allergies, the demand for intradermal injections has also increased in North America, which is bolstering the intradermal injection market growth.

Exhibit: North America Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)

North America Intradermal Injections Market Segmentation

The North America intradermal injections market is segmented on the basis of method, application, end user, and country. Based on method, the market is segmented into normal sized needle, short needle, and without needle. The normal sized needles segment registered the largest market share in 2021. The normal sized needles segment is further subsegmented into intradermal microinjections, microneedle arrays, and tattoo devices. The short needle segment is bifurcated into intradermal liquid jet injectors and ballistic intradermal injectors. In terms of application, the North America intradermal injections market is segmented into tuberculin skin test, allergy test, local aesthetics, and others. The tuberculin skin test segment held the largest market share in 2021. The North America intradermal injections market, by end user, is segmented into hospitals, diagnostic laboratories, academics and research institutes, and others. The hospitals segment held the largest market share in 2021. Based on country, the market is segmented into the US, Canada, and Mexico. The US dominated the market share in 2021.

BD; West Pharmaceutical Services, Inc; Terumo Corporation; Nanopass; PharmaJet; Idevax; EUNSUNG GLOBAL; Crossject; Cardinal Health Inc; and Hindustan Syringes and Medical Devices Ltd are the leading companies operating in intradermal injections market in North America.

The List of Companies - North America Intradermal Injections Market

● BD

● West Pharmaceutical Services, Inc.

● Terumo Corporation

● Nanopass

● PharmaJet

● Idevax

● EUNSUNG GLOBAL

● Crossject

● Cardinal Health Inc.

● Hindustan Syringes and Medical Devices Ltd.

TABLE OF CONTENTS

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Intradermal Injections Market – By Method

1.3.2 North America Intradermal Injections Market – By Application

1.3.3 North America Intradermal Injections Market – By End User

1.3.4 North America Intradermal Injections Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Intradermal Injections Market Landscape

4.1 Overview

4.2 NORTH AMERICA PEST ANALYSIS

4.3 EXPERT OPINIONS

5. North America Intradermal Injections Market - Key Market Dynamics

5.1 Key Market Drivers

5.1.1 Increasing Intradermal Vaccination

5.1.2 Increasing Incidences of diseases

5.1.3 Rising Acceptance of Aesthetic Procedures

5.2 Key Market Restraints

5.2.1 Risks, Complications, and Dosing Limitations Associated with Intradermal Injections

5.3 Key Market Opportunities

5.3.1 Significant Growth Opportunities in Developed as Well As Developing Countries

5.4 Future Trends

5.4.1 Strategic Developments by Manufacturers

5.5 Impact Analysis of Drivers and Restraints

6. Intradermal Injections Market– North America Analysis

6.1 North America Intradermal Injections Market, By Country - Forecast and Analysis

7. North America Intradermal Injections Market Revenue and Forecasts To 2028– By Method

7.1 Overview

7.2 North America Intradermal Injections Market, By Method, 2021 & 2028 (%)

7.3 Normal-Sized Needles (MANTOUX)

7.3.1 Overview

7.3.2 Normal-Sized Needles (Mantoux): Intradermal Injection Market Revenue and Forecasts To 2028 (US$ MN)

7.4 Short Needles

7.4.1 Overview

7.4.2 Short Needles: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

7.4.3 Intradermal Microinjection

7.4.3.1 Overview

7.4.3.2 Intradermal Microinjection: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

7.4.4 Microneedle Arrays

7.4.4.1 Overview

7.4.4.2 Microneedle Arrays: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

7.4.5 Tattoo Devices

7.4.5.1 Overview

7.4.5.2 Tattoo Devices: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

7.5 Without Needles

7.5.1 Overview

7.5.2 Without Needles: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

7.5.3 Intradermal Liquid Jet Injectors

7.5.3.1 Overview

7.5.3.2 Intradermal Liquid Jet Injectors: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

7.5.4 Ballistic Intradermal Injectors

7.5.4.1 Overview

7.5.4.2 Ballistic Intradermal Injectors: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

8. North America Intradermal Injections Market Revenue and Forecasts To 2028 – Application

8.1 Overview

8.2 North America Intradermal Injections Market Share by Application - 2021 & 2028 (%)

8.3 Tuberculin Skin Testing

8.3.1 Overview

8.3.2 Tuberculin Skin Testing Market Revenue and Forecast to 2028 (US$ Million)

8.4 Allergy Testing

8.4.1 Overview

8.4.2 Allergy Testing Market Revenue and Forecast to 2028 (US$ Million)

8.5 Local Aesthetics

8.5.1 Overview

8.5.2 Local Aesthetics Market Revenue and Forecast to 2028 (US$ Million)

8.6 OTHERS

8.6.1 Overview

8.6.2 Others Market Forecast and Analysis

9. North America Intradermal Injections Market Analysis - End User

9.1 Overview

9.2 North America Intradermal Injections Market, By End User, 2021 & 2028 (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)

9.4 Diagnostic Laboratories

9.4.1 Overview

9.4.2 Diagnostic Laboratories: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)

9.5 Academic and Research Institutes

9.5.1 Overview

9.5.2 Academic and Research Institutes: Intradermal Injections Market Revenue and Forecast to 2028 US$ Million)

9.6 OTHERS

9.6.1 Overview

9.6.2 Others: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)

10. North America Intradermal Injections Market Revenue and Forecasts To 2028 – Country Analysis

10.1.1 Overview

10.1.3 North America: Intradermal Injections Market, by Country, 2021 & 2028 (%)

10.1.3.1 US: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3.1.1 Overview

10.1.3.1.2 US: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3.1.3 US: Intradermal Injections Market, by Method, 2019–2028 (US$ Million)

10.1.3.1.3.1 US: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.1.3.1.3.2 US: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.1.3.1.4 US: Intradermal Injections Market, by Application, 2019–2028 (US$ Million)

10.1.3.1.5 US: Intradermal Injections Market, by End User, 2019–2028 (US$ Million)

10.1.3.2 Canada: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3.2.1 Overview

10.1.3.2.2 Canada: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3.2.3 Canada: Intradermal Injections Market, by Method, 2019–2028 (US$ Million)

10.1.3.2.3.1 Canada: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.1.3.2.3.2 Canada: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.1.3.2.4 Canada: Intradermal Injections Market, by Application, 2019–2028 (US$ Million)

10.1.3.2.5 Canada: Intradermal Injections Market, by End User, 2019–2028 (US$ Million)

10.1.3.3 Mexico: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3.3.1 Overview

10.1.3.3.2 Mexico: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3.3.3 Mexico: Intradermal Injections Market, by Method, 2019–2028 (US$ Million)

10.1.3.3.3.1 Mexico: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.1.3.3.3.2 Mexico: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.1.3.3.4 Mexico: Intradermal Injections Market, by Application, 2019–2028 (US$ Million)

10.1.3.3.5 Mexico: Intradermal Injections Market, by End User, 2019–2028 (US$ Million)

11. Industry Landscape

11.1 Overview

11.2 Developments

11.2.1 Overview

12. Company Profiles

12.1 BD

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 West Pharmaceutical Services, Inc.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Terumo Corporation

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 NanoPass

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Pharmajet

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Idevax

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 EUNSUNG GLOBAL

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Crossject

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Cardinal Health Inc.

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Hindustan Syringes and Medical Devices Ltd

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1. US Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 2. US: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 3. US: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 4. US Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 5. US Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 6. Canada: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 7. Canada: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 8. Canada: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 9. Canada Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 10. Canada Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 11. Mexico: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 12. Mexico: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 13. Mexico: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 14. Mexico Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 15. Mexico Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 16. Developments Done by Companies

Table 17. Glossary of Terms

The List of Companies - North America Intradermal Injections Market

● BD

● West Pharmaceutical Services, Inc.

● Terumo Corporation

● Nanopass

● PharmaJet

● Idevax

● EUNSUNG GLOBAL

● Crossject

● Cardinal Health Inc.

● Hindustan Syringes and Medical Devices Ltd.

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America intradermal injections market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the North America intradermal injections market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth North America market trends and outlook coupled with the factors driving the intradermal injections market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(North America Intradermal Injections Market Forecast to 2028)
  • Single User Price $3,000$2,400
  • Site Price $4,000$3,200
  • Enterprise Price $5,000$4,000
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry